Ironwood Pharmaceuticals | IRWD - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Akebia Therapeutics USD 265.42M 199K 2025-12
Almirall EUR 214.79M 0 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Astellas Pharma JPY 1.79B 81K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Charles River Laboratories USD 49.22M 2K 2025-12
Coherus Biosciences USD 121.16M 4.92M 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Incyte USD 199.95M 1.49M 2026-03
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
MacroGenics USD 63.32M 60K 2025-12
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 39.31M 1.81M 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Vanda Pharmaceuticals USD 58K 0 2024-12